KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

AbbVie (ABBV) Shares Repurchased (2016 - 2025)

AbbVie (ABBV) has disclosed Shares Repurchased for 13 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Repurchased fell 99.16% to $3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $980.0 million, a 42.62% decrease, with the full-year FY2025 number at $980.0 million, down 42.62% from a year prior.
  • Shares Repurchased was $3.0 million for Q4 2025 at AbbVie, down from $4.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $2.0 billion in Q1 2023 to a low of $3.0 million in Q4 2023.
  • A 5-year average of $354.0 million and a median of $10.0 million in 2021 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: surged 11833.33% in 2024, then plummeted 99.16% in 2025.
  • AbbVie's Shares Repurchased stood at $131.0 million in 2021, then tumbled by 96.95% to $4.0 million in 2022, then dropped by 25.0% to $3.0 million in 2023, then soared by 11833.33% to $358.0 million in 2024, then tumbled by 99.16% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Shares Repurchased are $3.0 million (Q4 2025), $4.0 million (Q3 2025), and $12.0 million (Q2 2025).